Headquartered in Maryland, Bridge Laboratories is a company focused on high-quality and cost-effective preclinical drug development services in the US and China for the pharmaceutical and biotechnology industries. Bridge recently acquired Gene Logic Laboratories. The combined company has more than 300 employees, and the capabilities now include nearly all aspects of US/EU/JP regulatory compliant preclinical drug discovery and development services.
Bridge recently opened a state-of-the-art animal vivarium in China in the prestigious Zhongguancun Life Sciences Park in Beijing. This facility was designed from the ground up to US accreditation standards, and operates under US-level GLP standards.
Bridge is a globally integrated (China- and US-focused) preclinical CRO with US level state-of-the-art facilities； AAALAC and US-level animal welfare protection； validated software and data acquisition； strict data security and encryption； global customs and shipping logistics； quality animal supply； US-level quality assurance training and compliance； project management, US board certified pathology services, English-only SOPs together with a motivated； client-centric, and highly trained and experienced staff.
Please visit www.bridgelaboratories.com for further information. If the national firewall blocks the US site, Please try http://www.freeproxyserver.ca/index.php?btxmnercdeqt=aHR0cDovL3d3dy5icmlkZ2VsYWJvcmF0b3JpZXMuY29t&hl=3ed
Welcome the most energetic, excellent ones to join us for drug development in China.